Found: 34
Select item for more details and to access through your institution.
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 1057, doi. 10.3390/cancers16051057
- By:
- Publication type:
- Article
Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 2, p. 1, doi. 10.1038/s41419-024-06488-x
- By:
- Publication type:
- Article
ARID1A Deficiency Regulates Anti-Tumor Immune Response in Esophageal Adenocarcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5377, doi. 10.3390/cancers15225377
- By:
- Publication type:
- Article
Stromal–Epithelial Interactions in Cancer Progression and Therapy Response.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 3020, doi. 10.3390/cancers15113020
- By:
- Publication type:
- Article
Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol.
- Published in:
- Biomedicines, 2023, v. 11, n. 5, p. 1392, doi. 10.3390/biomedicines11051392
- By:
- Publication type:
- Article
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR.
- Published in:
- Journal of Ovarian Research, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13048-023-01160-y
- By:
- Publication type:
- Article
The Relationship Between Periodontal Disease and Breast Cancer: From Basic Mechanism to Clinical Management and Prevention.
- Published in:
- Oral Health & Preventive Dentistry, 2023, v. 21, n. 1, p. 49, doi. 10.3290/j.ohpd.b3904343
- By:
- Publication type:
- Article
TGF-β controls stromal telomere length through epigenetic modifications.
- Published in:
- 3 Biotech, 2022, v. 12, n. 11, p. 1, doi. 10.1007/s13205-022-03346-5
- By:
- Publication type:
- Article
Fatty Acid Signaling Impacts Prostate Cancer Lineage Plasticity in an Autocrine and Paracrine Manner.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143449
- By:
- Publication type:
- Article
Antagonizing Glutamine Bioavailability Promotes Radiation Sensitivity in Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2491, doi. 10.3390/cancers14102491
- By:
- Publication type:
- Article
First-line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell Carcinoma: Where Are We Going, Where Have We Been?
- Published in:
- Drugs, 2022, v. 82, n. 4, p. 439, doi. 10.1007/s40265-022-01683-6
- By:
- Publication type:
- Article
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum].
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 5167, doi. 10.2147/ott.s315170
- By:
- Publication type:
- Article
Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk Stratification.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 528, doi. 10.46883/onc.2021.3509.0528
- By:
- Publication type:
- Article
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 4819, doi. 10.2147/OTT.S315170
- By:
- Publication type:
- Article
Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 3, p. 119, doi. 10.46883/onc.2021.3503.0119
- By:
- Publication type:
- Article
Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2854, doi. 10.3390/cancers12102854
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Stem Cells Translational Medicine, 2019, v. 8, n. 7, p. 739, doi. 10.1002/sctm.19-0068
- By:
- Publication type:
- Article
A Phase I Study to Assess the Safety and Cancer‐Homing Ability of Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer.
- Published in:
- Stem Cells Translational Medicine, 2019, v. 8, n. 5, p. 441, doi. 10.1002/sctm.18-0230
- By:
- Publication type:
- Article
Brain Complete Response to Cabozantinib prior to Radiation Therapy in Metastatic Renal Cell Carcinoma.
- Published in:
- Case Reports in Urology, 2019, p. 1, doi. 10.1155/2019/6769017
- By:
- Publication type:
- Article
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 9, p. 4639, doi. 10.1002/cam4.1695
- By:
- Publication type:
- Article
Porphyromonas gingivalis-Derived Lipopolysaccharide Combines Hypoxia to Induce Caspase-1 Activation in Periodontitis.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2017, p. 1, doi. 10.3389/fcimb.2017.00474
- By:
- Publication type:
- Article
Histone deacetylase inhibitors mediate DNA damage repair in ameliorating hemorrhagic cystitis.
- Published in:
- Scientific Reports, 2016, p. 39257, doi. 10.1038/srep39257
- By:
- Publication type:
- Article
A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer.
- Published in:
- Phytotherapy Research, 2015, v. 29, n. 6, p. 805, doi. 10.1002/ptr.5327
- By:
- Publication type:
- Article
A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054918
- By:
- Publication type:
- Article
Loss of epithelial oestrogen receptor α inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models.
- Published in:
- Journal of Pathology, 2012, v. 226, n. 1, p. 17, doi. 10.1002/path.2949
- By:
- Publication type:
- Article
Yes-Associated Protein Expression in Head and Neck Squamous Cell Carcinoma Nodal Metastasis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027529
- By:
- Publication type:
- Article
Serum Methionine Metabolites Are Risk Factors for Metastatic Prostate Cancer Progression.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0022486
- By:
- Publication type:
- Article
Bone Marrow Derived Mesenchymal Stem Cells Incorporate into the Prostate during Regrowth.
- Published in:
- PLoS ONE, 2010, v. 5, n. 9, p. 1, doi. 10.1371/journal.pone.0012920
- By:
- Publication type:
- Article
Identification of extracellular δ-catenin accumulation for prostate cancer detection.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 411, doi. 10.1002/pros.20902
- By:
- Publication type:
- Article
Bladder tissue formation from cultured bladder urothelium.
- Published in:
- Developmental Dynamics, 2006, v. 235, n. 10, p. 2795
- By:
- Publication type:
- Article
Loss of TGF-β type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-α-, MSP- and HGF-mediated signaling networks.
- Published in:
- Oncogene, 2005, v. 24, n. 32, p. 5053, doi. 10.1038/sj.onc.1208685
- By:
- Publication type:
- Article
Stromal fibroblasts in cancer initiation and progression.
- Published in:
- Nature, 2004, v. 432, n. 7015, p. 332, doi. 10.1038/nature03096
- By:
- Publication type:
- Article